Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Quinto J Gesiotto"'
Autor:
David M. Swoboda, Rashmi Kanagal-Shamanna, Andrew M. Brunner, Thomas Cluzeau, Onyee Chan, Najla Al Ali, Guillermo Montalban-Bravo, Quinto J. Gesiotto, Alexander Gavralidis, Anthony M. Hunter, Jung-Hoon Lee, Andrew T. Kuykendall, Chetasi Talati, Kendra L. Sweet, Jeffrey E. Lancet, Eric Padron, Mohammad Hussaini, Jinming Song, Guillermo Garcia-Manero, Rami S. Komrokji, David A. Sallman
Publikováno v:
Leukemia. 36(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a303e9fc1b13ae5f54faf774c3c3f1a
https://pubmed.ncbi.nlm.nih.gov/34975158
https://pubmed.ncbi.nlm.nih.gov/34975158
Autor:
Ashley Rose, Quinto J Gesiotto, Leidy Isenalumhe, Farhad Khimani, Hien D. Liu, Sameh Gaballa, Julio C. Chavez, Bijal D. Shah, Javier Pinilla Ibarz, Celeste Bello, Lubomir Sokol, Hayder Saeed
Publikováno v:
Blood. 138:2913-2913
Introduction: The standard of care for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous hematopoietic stem cell transplant (auto-HCT). Pre-apheresis absolute lymphocyte count (PA-ALC) is an independ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e7a6d358f1084207d57b4e546d57774
https://doi.org/10.1182/blood-2021-150542
https://doi.org/10.1182/blood-2021-150542
Autor:
Quinto J Gesiotto, David M Swoboda, Najla E. Al Ali, Eric Padron, Andrew T. Kuykendall, Jinming Song, Chetasi Talati, Kendra L. Sweet, Jeffrey E. Lancet, Rami Komrokji, David A. Sallman
Publikováno v:
Blood. 136:4-5
Background: Checkpoint inhibitors, for example anti-PD-1 antibodies (e.g. nivolumab and pembrolizumab) and anti-CTLA-4 antibodies (e.g. ipilimumab), have changed the paradigm of many solid tumors although in myeloid malignancies responses have been l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24a7f661b46d28b3468fb5bad04c415a
https://doi.org/10.1182/blood-2020-140861
https://doi.org/10.1182/blood-2020-140861
This evidence-based guide is the first of its kind to outline the surgical and perioperative management of patients with anatomical anomalies and support clinical decision-making under these difficult circumstances. Presented in a simple, accessible
